Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-01-14 Purchase | 2020-01-16 4:05 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 3,000 | $8.2255 | $24,677 | 6,545 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-04-15 Option Award | 2020-04-17 4:03 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 34 | $5.61 | 9,538 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:03 pm | N/A 2030-04-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 34 | $0 | 9,538 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A 2030-03-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 459 | $0 | 9,929 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 459 | $3.57 | 9,929 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:13 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 483 | $3.4 | 9,494 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:13 pm | N/A 2030-03-13 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 483 | $0 | 9,494 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:13 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 284 | $5.78 | 8,812 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:13 pm | N/A 2030-02-28 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 284 | $0 | 8,812 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:48 pm | N/A 2030-02-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 229 | $0 | 8,473 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:48 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 229 | $7.14 | 8,473 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 4:01 pm | N/A 2030-01-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 282 | $0 | 8,297 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 4:01 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 282 | $5.82 | 8,297 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-17 4:14 pm | N/A 2030-01-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 1,188 | $0 | 8,921 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-17 4:14 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 1,188 | $6.7 | 8,921 (Direct) | View |
| 2020-01-09 Option Award | 2020-01-13 4:18 pm | N/A 2030-01-09 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 30,000 | $0 | 30,000 (Direct) | View |